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Abstract
Objectives:  Compare  tomosynthesis  to  mammography,  ultrasound,  MRI,  and  histology  for  the
detection and  staging  of  BI-RADS  4—5  anomalies,  as  a  function  of  breast  composition,  lesion
location,  size,  and  histology.
Patients  and  methods:  Seventy-ﬁve  patients  underwent  mammography,  tomosynthesis,  ultra-
sound, and  MRI.  The  diagnostic  accuracy  of  the  different  examinations  was  compared.
Results:  The  sensitivities  for  detection  were  as  follows:  92.5%  with  MRI,  79%  for  ultrasound,
75% for  tomosynthesis,  and  59.5%  for  mammography.  Tomosynthesis  improves  the  sensitivity  of
mammography  (P  =  0.00013),  but  not  the  speciﬁcity.  The  detection  of  multifocality  and  mul-
ticentricity  was  improved,  but  not  signiﬁcantly.  Tomosynthesis  identiﬁed  more  lesions  than
mammography  in  10%  of  cases  and  improved  lesion  staging  irrespective  of  the  density,  but
was still  inferior  to  MRI.  The  detection  of  ductal  neoplasia  was  superior  with  tomosynthesis
than with  mammography  (P  =  0.016),  but  this  was  not  the  case  with  lobular  cancer.  The  visual-
ization of  masses  was  improved  with  tomosynthesis  (P  =  0.00012),  but  not  microcalciﬁcations.
Tomosynthesis  was  capable  of  differentiating  lesions  of  all  sizes,  but  the  smaller  lesions  were
easier to  see.  Lesion  sizes  measured  with  tomosynthesis,  excluding  the  spicules,  concurred  with
histological  dimensions.  Spicules  lead  to  an  overestimation  of  the  size.
Conclusion:  In  our  series,  tomosynthesis  found  more  lesions  than  mammography  in  10%  of
patients, resulting  in  an  adaption  of  the  surgical  plan.
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∗ Corresponding author.
E-mail address: Sylvie.LEMERY@cjp.fr (S. Lemery).
http://dx.doi.org/10.1016/j.diii.2014.06.010
2211-5684/© 2014 Éditions franc¸aises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
2l
t
p
t
o
d
I
r
s
9
i
r
r
+
i
l
o
t
a
p
b
m
•
•
•
•
•
P
T
p
b
s
C
o
f
r
c
M
c
e
o
(
c
a
m
E
I
P
a
a
p
a
g
a
s
F8  
The  improved  prognosis  [1]  for  breast  cancers  is  partly
inked  to  advances  in  treatment.
Optimal  staging,  to  determine  the  size  of  the  tumor  and
he  presence  of  additional  lesions,  is  essential  for  appro-
riate  surgery  with  healthy  margins.  Multifocality  (more
han  two  lesions  in  the  same  quadrant),  multicentricity  (two
r  more  lesions  in  different  quadrants),  or  contralateral
isease  [2,3]  may  require  more  extensive  breast  surgery.
gnorance  of  additional  lesions  affects  relapse  and  survival
ates,  but  the  literature  is  not  consensual  [4].
To  detect  these  multiple  lesions,  mammography  has  a
ensitivity  of  less  than  50%  [5—9],  and  mammary  MRI  of
4—99%  [5,9—13].
Tomosynthesis,  a  new  technique  in  3D  breast  imag-
ng,  acquires  reconstructed  volume  data,  the  data  is
econstructed  secondarily  in  mammary  slices  from  several
adiographs  acquired  from  different  angles  of  view  (−25◦ to
25◦ for  Siemens®).  It  theoretically  improves  the  sensitiv-
ty  of  detection  by  enabling  enhanced  delimitation  of  the
esion  margins,  and  the  speciﬁcity  by  avoiding  the  problem
f  glandular  superimposition  [14].
The  main  objective  of  this  study  was  to  compare
omosynthesis  with  2D  mammography  (Fig.  1a  and  b,  Fig.  2a
nd  b),  ultrasound,  and  MRI  (Fig.  3a  and  b)  in  cases  with  sus-
ected  BI-RADS  4  or  5  anomalies,  to  determine  its  potential
eneﬁt  for  staging,  and  in  particular  for  multifocality  and
ulticentricity.  The  secondary  objectives  were:
the  detection  of  contralateral  tumors;
to  calculate  the  sensitivity,  speciﬁcity,  and  positive  and
negative  predictive  values  (PPV  and  NPV)  of  tomosynthe-
sis  in  comparison  with  mammography  for  all  of  the  lesions;
to  grade  the  various  imaging  techniques  using  a  qualita-
tive  ‘‘TOMOS’’  score  for  clinical  performance;
the  comparative  analysis  of  tomosynthesis  and  mammog-
raphy  for  lesion  detection  according  to  breast  density,
histology,  signal  (mass,  microcalciﬁcation),  breast  topog-
raphy,  and  volume;
the  comparison  of  lesion  sizes  with  tomosynthesis  versus
histology.
•
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igure 1. Left mammography: a: anteroposterior mammography; b: oJ.  Mercier  et  al.
atients and methods
he  study  was  prospective  and  monocentric,  with  75
atients  included  between  2012  and  2013;  it  was  approved
y  the  Committee  for  the  Protection  and  Privacy  of  per-
ons  involved  in  clinical  trials,  the  ANSM,  and  the  scientiﬁc
ommittee  of  the  establishment.
The  patients  were  addressed  to  senology  for  the  staging
f  a  BI-RADS  4  or  5  lesion.  The  priority  for  inclusion  was
or  patients  with  an  indication  for  MRI,  in  compliance  with
ecommendations  (neoadjuvant  treatment,  invasive  lobular
arcinomas,  young  women,  high  family  risk).
The  criteria  for  non-inclusion  were  contraindications  for
RI,  pregnancy,  and  cognitive  disorders  preventing  informed
onsent.
Each  patient  underwent,  for  each  breast,  clinical
xamination,  2D  mammography  (anterior-posterior,  lateral
blique,  and  additional  views  if  necessary),  tomosynthesis
anterior-posterior,  lateral),  ultrasound,  biopsies  of  suspi-
ious  lesions,  MRI,  and  if  necessary  a  2nd  look  ultrasound
nd  biopsies  of  additional  lesions.
We  used  mammography  with  tomosynthesis  (Mammo-
at  Inspiration® from  Siemens®),  ultrasound  (Voluson  730
xpert® of  General  Electric®,  Aixplorer  of  Supersonic
maging®),  and  MRI  (1.5  T  General  Electric® and  1.5  T
hilips®).
These  examinations  were  re-read  by  two  senologists  (15
nd  20  years  of  experience),  in  double  blind,  who  were
ware  of  the  clinical  presentation.  The  ﬁrst  reading  was
rospective,  the  second  retrospective.
The  data  collected  for  each  patient  were  as  follows:  sex,
ge,  menopausal  status,  previous  history  of  breast  cancer,
enetic  mutations,  the  palpable  nature  of  the  main  lesion,
nd  the  size  of  the  breast  (small,  medium,  or  large).
We  recorded  the  following  parameters  for  the  main  and
atellite  lesions:
breast  density;
the  type  of  lesion  (mass,  microcalciﬁcation,  architectural
distortion);
blique mammography.
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Figure 2. Tomosynthesis for the same patient as in Fig. 1: a: anteroposterior tomosynthesis; b: lateral tomosynthesis.
f gadFigure 3. Axial MRI sections, T1 fat suppression after injection o
satellite lesion.• a qualitative  ‘‘TOMOS’’  score  representing  the  perfor-
mance  of  each  technique  (mammography,  ultrasound,
tomosynthesis,  and  MRI)  for  staging.  This  score  is  the  sum
of  the  points  attributed  to  each  imaging  technique  (fromolinium, at 2 minutes, in the same patient: a: principal lesion; b:1  for  the  worst  examination  for  staging  to  4  for  the  best)
for  each  of  the  following  3  criteria:
◦ number  of  suspicious  lesions  (≥  BI-RADS  3).  The  ref-
erence  was  histological,  taking  into  account  both
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principal  and  satellite  lesions  in  patients  who  were
operated  on  from  the  outset,  or  residual  lesions,  or
scarring  in  the  event  of  neoadjuvant  chemotherapy,
◦ concordance  of  the  BI-RADS  classiﬁcation  (from  3  to  5)
for  each  suspect  lesion  and  each  imaging  technique,
◦ variation  of  the  lesion  volume  (as  a  percentage)  for
each  imaging  technique;  the  reference  was  the  histol-
ogy  if  the  patient  was  operated  on  at  the  outset,  and
the  initial  MRI  if  neoadjuvant  chemotherapy  had  made
the  lesion  regress;
the  location  of  the  tumor  within  the  mammary  quad-
rants  and  the  depth  (anterior-middle-posterior)  of  the
tumor  seen  on  the  mammographies  and  tomosyntheses.
The  depth  was  determined  by  measuring  the  distance
between  the  nipple  and  the  pectoral  muscle,  and  sepa-
rating  it  into  three  equal  parts.  The  third  that  is  closest  to
the  nipple  was  designated  as  ‘‘anterior’’,  the  third  clos-
est  to  the  pectoral  as  ‘‘posterior’’,  and  the  last  third  as
the  ‘‘middle’’;
the  tumor  histology:  type  (ductal,  lobular,  in  situ,  other),
SBR  grade,  hormone  receptors  (estrogens,  progesterone),
HER2,  Ki67;
the  sensitivities,  speciﬁcities,  NPV,  and  PPV  of  the  imaging
techniques  as  a  function  of  the  histology.
The  descriptive  statistical  analysis  determined  the  fre-
uencies  for  the  qualitative  variables  and  the  distribution
arameters  for  the  quantitative  variables.
For  the  comparative  analysis,  the  calculations  for  sensi-
ivity,  speciﬁcity,  NPV,  and  PPV,  were  performed  using  the
EM  software  program  [15].  Chi2 tests  were  used  to  compare
he  rates  obtained  for  each  group  of  patients  according  to
he  imaging  techniques.
The  scores  and  volumes  were  compared  using  the  Student
-test  and  Mann  and  Whitney  U  test.  The  imaging  techniques
ere  compared  for  the  same  groups  of  patients  using  the
-test  for  unpaired  series.  The  Pearson  test  was  used  to
ompare  the  lesion  volumes.
esults
eventy-ﬁve  patients  were  included  and  150  breasts  exam-
ned;  124  malignant  lesions  were  found.
There  were  74  women  (98.6%)  and  one  man  (1.4%),  the
ean  age  was  55  years.  Fifty-two  percent  of  the  patients
ad  passed  the  menopause,  10%  had  a  previous  history  of
reast  cancer,  and  2.5%  had  a  genetic  mutation.
Out  of  the  75  affected  patients,  there  were  75  homolat-
ral  principal  lesions  and  4  contralateral  principal  lesions.
t
n
m
Table  1  Number  of  malignant  lesions  detected  on  histology  a
Lesions  seen  (number)  Localization
All  of  the  breasts  
Histopathology  124  
MRI  115  
1st  look  ultrasound  98  
Mammography  74  
Tomosynthesis  93  J.  Mercier  et  al.
ut  of  these  79  principal  lesions,  67  were  palpable  (84.8%),
2  subclinical  (15.2%),  20  multifocal  (25%),  and  13  multicen-
ric  (16.5%).
Bilateral  disease  was  found  in  4  of  the  75  patients  (5%).
On  histology,  124  malignant  lesions  were  diagnosed  (prin-
ipal  and  satellite);  118  homolateral  and  6  contralateral.
ighty-one  tumors  were  operated  on  immediately  and  43
nderwent  neoadjuvant  chemotherapy.
The  mammographic  appearance  for  86  tumors  (69%)
orresponded  to  a  mass,  for  22  lesions  (17.5%)  to  micro-
alciﬁcations,  and  for  16  cases  (13.5%)  to  an  architectural
istortion  or  various  associations.
Spicules  were  present  in  55  of  the  124  lesions  (44.5%).
The  tumors  were  predominant  in  the  superolateral  quad-
ants  (31%).  We  counted  86  lesions  with  an  anterior  and
iddle  topography  (69%),  and  38  posterior  (31%).
We  found  50.5%  invasive  ductal  carcinomas  (IDC),  33%
nvasive  lobular  (ILC),  15.2%  in  situ,  and  1.3%  other  lesions.
The  SBR  grades  were  1  in  13%,  2  in  79.5%,  and  3  in  7.5%
f  cases.  Estrogen,  progesterone,  and  Her  2  receptors  were
ositive  in  85%,  71%,  and  9%  of  lesions.
The  comparison  of  volumes  in  imaging  and  histology  was
ossible  for  65  tumors,  with  30  that  were  less  than  1  cm3
46%)  and  35  greater  than  1  cm3 (54%).
The  overall  detection  sensitivity  was  92.5%  with  MRI,  79%
ith  ultrasound,  59.5%  with  mammography,  and  75%  with
omosynthesis  (Tables  1  and  2).  Overall  lesion  detection
as  signiﬁcantly  improved  by  tomosynthesis  (P  = 0.00013)  in
omparison  with  mammography,  with  a slight  reduction  in
peciﬁcity  (P  =  0.27)  (Table  3).
Tomosynthesis  detected  additional  lesions  to  mammog-
aphy  in  8  patients  out  of  75  (10.5%)  and  MRI  in  13  patients
ut  of  75  (17%).  Tomosynthesis  did  not  reveal  any  lesions
hat  were  not  seen  on  MRI.
The  increase  in  sensitivity  of  tomosynthesis  for  multifo-
ality  and  multicentricity  was  25%  and  15%  in  comparison
ith  mammography,  but  this  was  not  statistically  signiﬁcant
P  =  0.11  and  P  =  0.67),  due  to  the  small  sample  size.
According  to  the  ‘‘TOMOS’’  score  (Table  4),  lesion  eval-
ation  was  better  with  MRI  (score  of  3.8/4)  than  with
omosynthesis  and  ultrasound  (2.6/4),  or  mammography
1.9/4).
According  to  the  ‘‘TOMOS’’  score,  tomosynthesis  did
ot  classify  the  lesions  better  than  mammography  in  very
ense  or  very  clear  breasts  (type  1  or  4)  (P  =  0.14  and
 =  0.056),  but  the  population  was  small  (8  patients).  For
ype  2  and  3  breasts,  the  beneﬁt  of  tomosynthesis  was  sig-
iﬁcant  (P  =  0.000026  and  P  =  0.00022).
MRI  was  superior  to  tomosynthesis  for  breasts  with  inter-
ediate  densities  (type  2  or  3)  (P  <  10−7)  and  high  densities
nd  for  each  breast  imaging  technique.
Homolateral  breast  Contralateral  breast
118  6
110  5
92  6
73  1
88  5
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Table  2  Sensitivity  (as  a  %)  of  tumor  detection  for  each  breast  imaging  technique  in  our  study.
Sensitivity  (%)  Localization
All  of  the  breasts  Homolateral  breast  Contralateral  breast
Histopathology  100  100  100
MRI  92.5  93  83
1st  look  ultrasound  79  78  100
Mammography  59.5  62  17
Tomosynthesis  75  74.5  83
Table  3  Comparison  of  the  diagnostic  performance  of  mammography  and  of  tomosynthesis  for  the  124  malignant  lesions
in  our  series.
Mammography  Tomosynthesis
Sensitivity  (%) 59.5 75
Speciﬁcity  (%) 81.6 74.4
NPV  (%) 53.0 66.7
PPV  (%) 81.6
Table  4  ‘‘TOMOS’’  score  for  each  breast  imaging
technique.
Imaging  technique ‘‘TOMOS’’  score  (out  of  4  points)
Mammography  1.9  (standard  deviation  1.0)
Tomosynthesis  2.6  (standard  deviation  0.9)
Ultrasound  2.6  (standard  deviation  0.8)
MRI  3.8  (standard  deviation  0.5)
The ‘‘TOMOS’’ score is calculated by giving a score for each
imaging technique for each of the following three criteria:
concordance of the number of suspected lesions, of the BI-RADS
classiﬁcation of these lesions, and of tumor volume with the
histological reference if the patients underwent immediate
surgery, or if not with the size measured on MRI if they under-
went neoadjuvant chemotherap. This resulted in a grading
system for the various imaging techniques, where a ‘‘TOMOS’’
score of 1 was attributed to the worst examination and 4 to the
most effective examination.
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Skaane  et  al.  [20],  combining  tomosynthesis  and  mam-
mography  reduced  false  positives  by  15%  (P  <  0.001)  in(type  4)  (P  =  0.0023),  but  there  was  no  difference  between
tomosynthesis  and  MRI  for  type  1  densities.
The  sensitivity  of  tomosynthesis  according  to  various
criteria  was  as  follows:
• 3D  mammography  was  superior  to  2D  mammography  in
low-density  breasts  reputed  as  easy  (1  and  2)  (P  =  0.011),
and  in  more  dense  breasts  reputed  as  difﬁcult  (3  and  4)
(P  =  0.037).  This  increase  in  sensitivity  was  identical  (20%)
in  clear  or  dense  breasts;
• the  detection  of  ductal  forms  was  increased  with
tomosynthesis  (P  =  0.016),  but  not  that  of  lobular  forms
(P  =  0.17);
• the  sensitivity  of  detection  of  masses  was  improved
by  tomosynthesis  (P  =  0.0012),  with  a  20%  increase  in
comparison  with  mammography.  The  visualization  of
microcalciﬁcations  was  not  improved  with  tomosynthesis
(P  =  0.75);
c
c81.6
tomosynthesis  improved  the  detection  of  lesions,  irre-
spective  of  their  mammary  topography,  with  an  increase
of  20%;
the  detection  of  small  lesions  (≤  1  cm3) was  superior  with
tomosynthesis  compared  to  mammography  (P  =  0.0039),
but  there  was  no  signiﬁcant  difference  for  larger  tumors
(>  1  cm3)  (P  =  0.25).
The  lesion  volumes  measured  with  tomosynthesis,  with-
ut  the  spicules,  was  concordant  with  histological  ﬁndings
overestimation  of  2.2%),  but  signiﬁcantly  overestimated
P  =  0.000014)  if  the  spicules  were  included.
iscussion
he  patients  included  in  this  study  presented  speciﬁc  char-
cteristics.  Firstly,  the  women  all  had  breast  neoplasia:
ultifocal,  multicentric,  and  bilateral  forms  were  therefore
ore  numerous  than  in  the  general  population.  Secondly,
nvasive  lobular  types  were  over-represented  by  a  factor  of
hree  (33%  in  the  study,  10%  in  the  general  population)  [16].
The  detection  sensitivities  were  92.5%,  79%,  75%,  and
9.5%  with  MRI,  ultrasound,  tomosynthesis,  and  mam-
ography  respectively.  This  15%  increase  in  detection
ate  with  tomosynthesis  in  comparison  with  mammography
P  =  0.00013)  concurs  with  other  studies,  where  it  has  been
eported  to  be  between  10  and  15%  [17,18].  Recent  series
ave  shown  improved  detection  sensitivity  with  tomosynthe-
is,  either  alone  with  two  incidences,  or  with  one  incidence
ssociated  with  two  views  of  mammography  [19].
However,  we  did  not  record  any  difference  in  speciﬁcity
etween  tomosynthesis  and  mammography  (P  =  0.27).
Recent  studies  have  reported  improved  speciﬁcity  with
omosynthesis  through  a  reduction  in  false  positives.  Foromparison  with  mammography  alone.  For  Gur  et  al.  [19],  a
ombination  of  tomosynthesis  and  mammography  increased
3 J.  Mercier  et  al.
t
a
T
[
l
m
o
d
R
1
l
b
r
t
i
t
t
o
r
i
s
c
b
(
i
[
t
l
r
[
c
e
m
i
T
f
s
t
w
r
e
i
o
s
w
i
d
s
t
d
d
i
e
2
m
Sensitivity 
1+2 3+4 
 MRI 
 To mosynthe sis 
 Mammog raphy 50% 
100% 
         Breast density 
Figure 4. Variations in lesion detection sensitivities with mam-
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he  speciﬁcity  by  8%  in  comparison  with  tomosynthesis
lone,  and  by  12%  in  comparison  with  mammography  alone.
omosynthesis  reduced  recall  screenings  by  40%  for  Rafferty
17].  In  our  series,  the  speciﬁcity  of  tomosynthesis  (74.4%)  is
ower  than  that  of  mammography  (81.6%).  This  result,  at  the
argin  of  the  literature,  could  be  explained  by  the  fact  that
ur  study  involved  staging  rather  than  screening,  with  the
iscovery  of  a  higher  proportion  of  theoretically  benign  BI-
ADS  3  anomalies  (17  BI-RADS  3  lesions  with  mammography,
8  with  tomosynthesis).  Since  the  patients  included  had  at
east  one  breast  cancer,  the  readers  may  have  over-classiﬁed
orderline  BI-RADS  2  or  3  lesions  into  the  category  above,
educing  the  speciﬁcity  of  tomosynthesis  at  the  expense  of
he  sensitivity.  Studies  showing  an  improved  speciﬁcity  only
ncluded  BI-RADS  4  and  5  lesions  [19,21—23].
Tomosynthesis  increased  sensitivity  by  25%  and  15%  for
he  detection  of  multifocality  and  multicentricity  respec-
ively,  but  this  was  not  signiﬁcant  (P  =  0.11  and  P  =  0.67),  as
ur  small  sample  size  decreased  the  statistical  power.  The
ate  of  multifocal/multicentric  cancers  was  25%  and  16.5%
n  our  series,  and  close  to  29%  and  18%  in  mastectomy  tissue
amples  recorded  by  Sardanelli  et  al.  [13].
No  other  study  has  evaluated  tomosynthesis  for  multifo-
ality  and  multicentricity.  The  search  for  signiﬁcance  could
e  undertaken  on  a  larger  sample  size  for  multifocality
P  =  0.11  could  become  signiﬁcant).
We  counted  around  twice  as  many  contralateral  lesions
n  our  series  (5%)  than  in  the  general  population  (1  to  3%)
24—26].
Tomosynthesis  detected  additional  lesions  that  altered
he  therapeutic  strategy  in  10%  of  cases  (conversion  from
umpectomy  to  quadrantectomy  or  mastectomy).  MRI,  the
eference  for  detecting  multicentricity  and  multifocality
13,27,28]  resulted  in  a  modiﬁed  treatment  plan  in  17%  of
ases,  which  concurs  with  the  20%  reported  by  Houssami
t  al.  [29].
Performing  tomosynthesis  after  a  BI-RADS  4  or  5  mam-
ography  would  result  in  the  detection  of  additional  lesions
n  10%  of  cases,  resulting  in  a  potentially  wider  surgery.
omosynthesis  could  be  useful  in  ‘‘1-day  senology  workups’’,
avored  by  patients,  where  the  biopsies  are  taken  on  the
ame  day  and  the  ﬁrst  diagnosis  given  by  the  surgeon  in
he  evening.  Additional  suspicious  lesions  in  tomosynthesis
ould  enable  the  surgeon  to  prepare  the  patient  for  a more
adical  surgery  than  originally  planned,  although  the  refer-
nce  for  additional  lesions  is  still  MRI,  performed  in  second
ntention.  Only  deﬁnitive  histology  enables  pronouncement
f  the  ﬁnal  treatment  [30].  Biopsies  guided  by  tomosynthe-
is  are  under  development  [31]  for  lesions  that  are  only  seen
ith  this  technique.
The  lesion  detection  of  mammographies  went  from  67%
n  clear  breasts  to  50%  in  dense  breasts.  The  sensitivity
ecreases  as  breast  density  increases  [32]  due  to  tissue
uperimposition  [33,34].  The  improvement  in  lesion  detec-
ion  with  tomosynthesis  was  not  affected  by  radiological
ensity,  the  increased  sensitivity  being  identical  in  clear  and
ense  breasts  (20%)  (Fig.  4).
The  detection  performances  of  MRI  were  also  constant
rrespective  of  the  density  and  far  superior  to  the  other
xaminations  [13],  the  ‘‘TOMOS’’  score  being  3.8/4  in  MRI,
.6/4  in  tomosynthesis  and  ultrasound,  and  1.9/4  with  mam-
ography.
d
o
wography, tomosynthesis, and MRI, as a function of the breast
ensity according to the BI-RADS classiﬁcation.
The  sensitivity  was  improved  by  tomosynthesis  in
omparison  with  mammography  for  inﬁltrative  ductal  histo-
ogical  forms  (P  =  0.016).  However,  the  poor  performances  of
ammography  for  inﬁltrative  lobular  carcinomas  [35]  were
ot  improved  by  tomosynthesis  (P  =  0.17).  MRI  is  still  the  ref-
rence  for  ductal  forms  (sensitivity  of  96%)  according  to  Berg
t  al.  [36].
There  was  no  difference  in  the  visualization  of  micro-
alciﬁcations  between  tomosynthesis  and  mammography
P  =  0.07).  The  literature  does  not  show  any  clear  beneﬁt
or  tomosynthesis.  Microcalciﬁcations  seem  to  be  easier  to
valuate  on  mammography  with  superpositions,  than  on  the
illimetric  slices  of  tomosynthesis,  which  make  it  harder
o  study  their  morphology  and  distribution  [23,37—39].  The
ong  acquisition  time  in  tomosynthesis  can  cause  a  distur-
ing  kinetic  blur.  The  analysis  of  microcalciﬁcations  with
omosynthesis  would  necessitate  an  increase  in  slice  thick-
ess  using  post-treatment  techniques  [40].
Mammography  is  currently  still  the  reference  for  micro-
alciﬁcations  [37,41].
However,  the  detection  of  masses  was  superior  with
omosynthesis  than  with  mammography  (P  = 0.0012)  [42,43],
y  improved  visibility  of  the  lesion  margins  and  spicules  [44].
Anterior  or  middle  mammary  lesions  were  detected  bet-
er  than  posterior  lesions.  However,  tomosynthesis  proved  to
e  superior  to  mammography,  irrespective  of  the  location  of
he  tumor  (P  =  0.00038).  We  expected  improved  visualization
f  posterior  lesions  in  mammography  than  with  tomosyn-
hesis,  given  that  the  depth  of  exploration  is  limited  in
omosynthesis  by  a  small  range  of  mammary  compression,
ut  this  was  not  the  case  in  practice.
Mammography  detected  large  lesions  (>  1  cm3) much  bet-
er  than  smaller  ones  (P  =  0.01)  [45].  Tissue  superimposition
indered  the  visualization  of  small  tumors  buried  in  the
ammary  parenchyma  [46].
Tomosynthesis  presented  a  constant  sensitivity  (68.5%),
rrespective  of  the  size  of  the  lesion,  with  a  superior  increase
or  small  tumors  under  1  cm3 (P  =  0.0039),  through  a  reduc-
ion  in  the  phenomena  of  convergence  [14].  This  stable
etection  sensitivity,  irrespective  of  lesion  size,  is  also
bserved  with  MRI  [45].
Tumor  volumes  in  mammography,  ultrasound,  and  MRI
ere  concordant  with  the  histology  [47].
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Tumor  size  in  tomosynthesis,  without  including  the
spicules,  were  concordant  with  histology  (overestimation  of
2%  of  the  mean  volume)  through  an  improved  delimitation
of  the  margins.
Concordance  of  tumor  size  between  tomosynthesis  and
other  imaging  techniques  has  been  studied.  Luparia  et  al.
[47]  demonstrated  that  the  measurement  of  lesion  sizes
(largest  diameter)  was  superior  with  MRI  and  tomosynthesis
than  with  mammography  or  ultrasound,  in  comparison  with
the  histology  reference.  For  Fornvik  et  al.  [48],  tomosyn-
thesis  measurements  (largest  dimension)  were  more  closely
correlated  to  histology  than  the  mammographic  dimensions
(correlation  coefﬁcients  of  0.86  and  0.71  respectively).
Spicules  should  not  be  included,  as  they  signiﬁcantly
overestimate  the  size  of  the  lesion  (P  =  0.000014),  since  they
are  essentially  composed  of  peritumoral  ﬁbrosis  [49,50].
Tomosynthesis  delineates  the  spicules  better  than  mammog-
raphy  and  so  signiﬁcantly  overestimated  the  size  of  the
lesions  (P  =  0.028)  when  these  spicules  were  included.
In  conclusion,  it  is  important  to  know  how  to  use  tomosyn-
thesis  as  a  function  of  the  indication,  depending  on  whether
the  examination  is  for  screening  or  diagnosis  as  in  our  study.
For  screening,  the  additional  radiation  associated  with
tomosynthesis  (equivalent  to  1.4  mammography  ﬁlms)  [51]
should  also  be  considered.  A  dosimetric  study  carried  out
on  our  machine  showed  that  the  dose  of  one  tomosynthe-
sis  incidence  was  identical  to  one  standard  mammography
ﬁlm  [52].  One  tomosynthesis  ﬁlm  is  often  proposed  in  addi-
tion  to  the  standard  two  2D  mammography  ﬁlms  per  breast,
increasing  detection  without  signiﬁcantly  increasing  irradi-
ation,  as  described  by  Svahn  et  al.  [53].  Skaane  et  al.  [20]  in
their  study  of  18,000  patients,  demonstrated  a  30%  increase
in  detection  by  adding  one  incidence  of  tomosynthesis  per
breast  to  the  standard  two  mammography  ﬁlms  (anteropos-
terior  and  oblique).
With  a  clinical  anomaly  or  a  BI-RADS  4  or  5  mammogram,
as  in  our  study,  the  aim  is  to  characterize  the  lesion  and  to
look  for  additional  lesions  that  may  alter  the  treatment  pro-
tocol.  The  dosimetry  in  such  cases  is  not  so  important.  We
could  then  privilege  the  use  of  two  orthogonal  tomosynthesis
views  (anteroposterior  and  lateral),  signiﬁcantly  improv-
ing  the  detection  of  lesions  in  comparison  with  a  single
tomosynthesis  view  or  two  2D  mammography  incidences
[54—56].
Conclusion
In  this  prospective  monocentric  series  of  75  patients,  all  of
whom  had  one  BI-RADS  4  or  5  lesion,  tomosynthesis  (two
views)  signiﬁcantly  increased  the  sensitivity  of  the  detec-
tion  of  masses,  invasive  ductal  carcinomas,  and  small  lesions
(through  improved  visualization  of  the  margins),  and  in
breasts  with  an  intermediate  density  for  BI-RADS  type  2  and
3.
It  did  not  provide  any  advantages  for  the  detection  of
microcalciﬁcations  or  invasive  lobular  carcinomas.
Our  qualitative  ‘‘TOMOS’’  score,  comparing  the  different
imaging  techniques  for  staging,  demonstrated  that  tomosyn-
thesis  was  superior  to  mammography  alone,  and  came  close
to  the  performances  of  ultrasound  and  to  a  lesser  degree  to
MRI.
[33
In  our  series,  there  was  improved  visibility  of  additional
esions  in  10%  of  patients.  The  detection  sensitivity  for  multi-
ocality  and  multicentricity  was  improved  by  tomosynthesis,
ut  this  was  not  statistically  signiﬁcant.  MRI  was  still  the
ost  effective  technique.
The  use  of  tomosynthesis  as  a complement  to  an  abnor-
al  BI-RADS  4  or  5  mammography  proved  beneﬁcial  for
reparing  surgery  (wide  lumpectomy  or  mastectomy)  in  1
ut  of  10  patients,  even  though  MRI  was  still  the  most  effec-
ive  means  of  detecting  additional  lesions.
In  this  series,  tomosynthesis  proved  superior  to  2D  mam-
ography.  It  also  improved  the  interpretation  of  other
maging  techniques  (ultrasound  and  MRI),  without  however
eplacing  them.
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